Silence Therapeutics plc
SLNNasdaqCIK 1479615Healthcare
Reports and events: 116 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1912:05 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-424695 |
| 2026-08-1301:55 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-096202 |
| 2026-08-1221:23 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-347196 |
| 2026-08-1011:57 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-341293 |
| 2026-08-1011:26 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-341248 |
| 2026-08-1011:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-341240 |
| 2026-07-1621:20 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0001193125-26-306251 |
| 2026-07-0811:00 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-081559 |
| 2026-06-2320:35 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-279577 |
| 2026-06-1621:00 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-272814 |
| 2026-06-1111:35 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-266705 |
| 2026-05-1821:00 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-229089 |
| 2026-05-0712:22 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-210446 |
| 2026-05-0712:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-210428 |
| 2026-04-2920:23 ET | DEF 14A | Proxy statementPeriod 2026-06-16 | 0001193125-26-191786 |
| 2026-03-0512:49 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-092591 |
| 2026-03-0512:40 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-092578 |
| 2025-12-2221:01 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0001193125-25-328684 |
| 2025-12-2212:32 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-327575 |
| 2025-12-1521:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-319156 |
| 2025-11-0612:53 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-268116 |
| 2025-11-0612:38 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-268102 |
| 2025-10-2311:45 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-247692 |
| 2025-08-1410:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-180313 |
| 2025-08-0712:04 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-104593 |
| 2025-08-0711:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-174958 |
| 2025-06-2711:00 ET | 8-K | 5.07 Shareholder vote results | 0001193125-25-149704 |
| 2025-06-2514:24 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-062458 |
| 2025-05-1610:05 ET | DEF 14A | Proxy statementPeriod 2025-06-26 | 0001193125-25-121232 |
| 2025-05-0814:18 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-045969 |
| 2025-05-0812:35 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-066439 |
| 2025-05-0812:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-115533 |
| 2025-05-0612:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-113364 |
| 2025-04-3020:30 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0000950170-25-061116 |
| 2025-04-2413:28 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-038392 |
| 2025-03-3114:50 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-029716 |
| 2025-02-2721:30 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-029129 |
| 2025-02-2721:13 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-039248 |
| 2025-01-0213:00 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-25-000144 |
| 2024-12-2022:32 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-24-130924 |
| 2024-12-0913:12 ET | 6-K | Report of a foreign private issuerPeriod 2024-12-09 | 0001193125-24-272929 |
| 2024-11-1821:54 ET | 6-K | Report of a foreign private issuerPeriod 2024-11-18 | 0001193125-24-260987 |
| 2024-11-1414:24 ET | 6-K | Report of a foreign private issuerPeriod 2024-09-30 | 0000950170-24-126791 |
| 2024-08-1513:05 ET | 6-K | Report of a foreign private issuerPeriod 2024-06-30 | 0000950170-24-097383 |
| 2024-06-2711:40 ET | 6-K | Report of a foreign private issuerPeriod 2024-06-27 | 0001193125-24-169739 |
| 2024-06-2412:38 ET | 6-K | Report of a foreign private issuerPeriod 2024-06-24 | 0001193125-24-166362 |
| 2024-06-2012:41 ET | 6-K | Report of a foreign private issuerPeriod 2024-06-20 | 0001193125-24-164042 |
| 2024-05-1721:04 ET | 6-K | Report of a foreign private issuerPeriod 2024-05-17 | 0001193125-24-141853 |
| 2024-05-1618:21 ET | 6-K | Report of a foreign private issuerPeriod 2024-03-31 | 0000950170-24-060977 |
| 2024-05-0120:37 ET | 6-K | Report of a foreign private issuerPeriod 2024-05-01 | 0001193125-24-127556 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:08 ET. Listed shows no prices and gives no investment advice.